Related Experiment Video
Updated: May 2, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
[Management of the cardiovascular complications of treatment in thoracic oncology]
S Ederhy1, A Hollebecque2, N Haddour1
1Service de cardiologie, hôpital Saint-Antoine, AP-HP, université Pierre-et-Marie-Curie [UPMC], Paris-Sorbonne, 184, rue du faubourg Saint-Antoine, 75571 Paris cedex 12, France.
Abstract:
The management of patients suffering from bronchial and lung tumors depends on conventional chemotherapy and/or targeted molecular therapies. The prescription of these chemotherapies may be accompanied by cardiovascular complications, principally congestive heart failure, arterial hypertension and arterial or venous thrombo-embolism, the frequency of which varies with the molecule administered. The management of these complications is currently poorly standardized and should take account of the patient's oncological prognosis.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Pericarditis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Mitral Stenosis IV: Nursing Management

